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Abstract  
 Introduction: Kidney function tests are requested to monitor the 
general status of kidney health in general, and particularly to assess renal 
failure status. 
Objectives: To investigate the efficacy of therapeutic options for renal 
failure patients through studying changes in selected laboratory 
investigations.. 
Methodology:  
A retrospective study design was involved  to review files of patients with 
kidney failure at Royal Medical Services. A total of 263 files were reviewed 
for kidney function tests over a period of three months. After the end of data 
collection, data were analyzed employing SPSS V20. The representation of 
data was as means and standard deviations. Kinetic changes were tested 
using paired T-test. Significance between variables was considered at an 
alpha < 0.05. 
Results  
Among study variable including Hematocrit (HCT), mean cell volume 
(MVC), blood urea nitrogen (BUN), creatinine, phosphorous, calcium, 
albumin, sodium, and potassium, there were insignificant changes except for 
BUN (p=0.004), sodium (p=0.013), and potassium (p=0.000). 
Conclusion  
From the results, following changes in the level of kidney function tests help 
in assessment of renal failure status as the progression of disease can be 
monitored. Understanding and comparing various laboratory findings help in 
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better monitoring of clinical status of patients.  
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Introduction  
 It has been estimated that about 35,000 deaths  occurred in United 
States yearly due to renal diseases (Waknine, 2007). Millions of patients 
have complained from various kidney diseases such as urinary tract 
infections, kidney stones and urinary obstruction (Alpers, 2004).  
 Chronic Renal Failure (CRF) has been described as a syndrome in 
which there is a continuous and irreversible alterations of renal function 
resulting from the damage of renal parenchyma, which may end with death if 
appropriate numbers of nephrons are damaged (Alpers, 2004; (Eknoyan et 
al., 2004). Patients with CRF are more likely to develop cardiovascular 
diseases (Al-Aly et al., 2010; Wang et al., 2011; Chen et al., 2012; Hallan et 
al., 2012). 
 There are various therapeutic options to treat CRF, but these options 
vary according to the underlying cause. Furthermore, complications 
associated CRF are treated to help patients coping with these complications. 
In case blood pressure has been encountered,  angiotensin-converting 
enzyme (ACE) inhibitors are prescribed. Patients usually suffer from 
increased levels of cholesterol, and statins are prescribed to lower cholesterol 
and to decrease the risk of heart disease. If anemia is encountered, 
erythropoietin is prescribed, sometimes with iron to help in production of red 
blood cells to help in get rid of fatigue and weakness associated with anemia. 
Sometimes, diuretics are given to relieve swelling. Calcium and vitamin D 
supplements are given to protect bones. In case of developing end-stage 
kidney disease, dialysis and kidney transplant are the potential therapeutic 
choices (Abecassis et al., 2008; Mayoclinic.org, 2015). 
 In a study conducted by Suresh et al (2012) to investigate the 
hematological changes including red blood cell (RBC) count, Hb 
concentration, hematocrit, and platelet count in patients with CRF, it was 
found that CRF had significantly decreased levels of variables under study 
(P<0.05) with control group. 
 Study objective: the main objective of this study is to investigate 
efficacy of therapeutic options for renal failure patients through studying 
changes in selected laboratory investigations. 
 
Methodology  
 This study employed retrospective design to collect data from files of 
patients with renal failure at Royal Medical services. A total of 262 files of 
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renal patients were reviewed. Two readings for each patient were taken and 
analyzed for the following laboratory investigations: Hematocrit (HCT), 
mean cell volume (MVC), blood urea nitrogen (BUN), creatinine, 
phosphorous, calcium, albumin, sodium, and potassium. The data of all 
patients included were entered into excel sheet to create raw data, and after 
that were transferred into SPSS version 20 for statistical analysis. Paired T 
test was used to investigate the significance between variables. Significance 
was considered at an alpha level < 0.05.  
 
Results 
First and second readings of laboratory investigation 
 As it can be seen from table 1, there were slight differences  in HCT 
reading, and second readings were slightly lower than the first reading. The 
level of MCV was higher in the second reading compared with the first 
reading (from about 87 to about 90). The level of BUN increased from 62to 
69.52. Slight increases in creatinine level were observed. Phosphorous levels 
increased slightly in the second readings. Calcium levels slightly decreased 
in the second reading. The level of albumin was slightly increased. Sodium 
level slightly decreased, and potassium level increased in the second reading. 
Table 1: First and second readings of laboratory investigation 
First reading  (M+SD) Second reading (M+SD) 
HCT (30.81+ 5.18) HCT (30.45+5.73) 
MCV (86.99+ 5.84) MCV (90.27+53.54) 
BUN (62+19.81) BUN (69.52+ 30.89) 
Creatinine (9.32+5.91)   Creatinine (9.35+ 3.22) 
Phosphorous (4.96+1.76) Phosphorous (5.48+6.51) 
Calcium (8.83+1.0) Calcium (8.75+0.98) 
Albumin (38.94+5.46) Albumin (39.14+7.69) 
Sodium (139.87+4.36) Sodium (138.85+4.29) 
Potassium (4.62+0.83) Potassium (4.99+0.96) 
 
Statistical variation in the level of laboratory investigations 
 In this section, there was an attempt to investigate if the variations 
between first and second readings were statistically significant. As shown in 
table 2, although some slight changes were observed, but they were not 
statistically significant (p >0.05), except for three investigations BUN 
(p=0.04), sodium (p=0.013), and potassium (p=0.000).  
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Table 2: Statistical variation in the level of laboratory investigations (Paired T test) 
First reading (M+SD) Second reading (M+SD) P value 
HCT (30.92+5.26) HCT (30.27+5.26) 0.214 
MCV (86.89+5.83) MCV (90.40+55.15) 0.357 
BUN (61.88+20) BUN (69.31+32.30) 0.004 
Creatinine (9.43+6.25) Creatinine (9.20+3.16) 0.611 
Phosphorous (4.75+1.83) Phosphorous (5.42+7.0) 0.193 
Calcium (8.81+1.0) Calcium (8.77+0.94) 0.689 
Albumin (39.18+4.75) Albumin (39.11+7.74) 0.919 
Sodium (140.02+4.05) Sodium (138.96+4.02) 0.013 
Potassium (4.65+0.82) Potassium (4.99+0.98) 0.000 
 
Discussion 
 The present study focused on kinetic changes of biomarkers for 
assessment of renal function of renal failure patients. Actually changes from 
time to time can help in monitoring of progression of disease and the 
efficacy of medications used. Our results showed the importance of 
continuous monitoring of laboratory investigations and the following points 
can be argued:  
1- hanges in the level of these investigations are necessary to be 
followed to monitor minor changes before being major changes and create 
further problems for the patients with renal failure (figure 1).  
2- Although, changes may be still statistically insignificant, but they can 
draw the line for disease progression. 
3- Our study indicated that three of investigations were statistically 
significant, BUN (p=0.004), sodium (p=0.013), and potassium (p=0.000).  
Increased level of BUN implies a deterioration in protein metabolism and 
this is in agreement with other studies (Dwinnell and Anderson, 2012; 
Kamal, 2014). On the other hand, deteriorations in the level of sodium and 
potassium indicate to complications related cardiovascular disease and 
therapeutics under use need to be assessed again (Mayoclinic.org, 2015). 
 
Conclusion 
 From the results, following changes in the level of kidney function 
tests help in assessment of renal failure status as the progression of disease 
can be monitored. Understanding and comparing various laboratory findings 
help in better monitoring of clinical status of patients.  
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Figure 1: Schematic diagram representing changes in the level of laboratory investigations 
for the first and second readings. 
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